It is well known that regular follow-up of HBsAg-positive patients to assess disease progression with the help of AFP tests, liver function tests, and abdominal ultrasound is clinically important for the prevention of cirrhosis and hepatocellular carcinoma. This evidence concerns the gene AFP and hepatocellular carcinoma.